- Home
- / ITeos Therapeutics
ITeos Therapeutics
Stock Price
$8.6
2024-10-29
Market Capitalization
$313.4 M
2024-10-29
Revenue
$35 M
FY, 2024
ITeos Therapeutics Summary
Company Summary
- Overview
- ITeos Therapeutics is a pharmaceutical company that develops immunotherapy solutions. It offers targeted immunotherapies for people living with cancer.
- Type
- Public
- Status
- Active
- Founded
- 2011
- HQ
- Watertown, MA, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Matthew Call, Chief Operating Officer
Philippe Brantegem, Chief HR / People Officer
LocationsView all
2 locations detected
Watertown, MA HQ
United States
321 Arsenal St Bldg 312, Suite 301
Charleroi, Wallonie
Belgium
29 Rue des Frères Wright
ITeos Therapeutics Financials
Summary Financials
- Net income (Q2, 2025)
- ($78.7M)
- Cash (Q2, 2025)
- $207.8M
- EBIT (Q2, 2025)
- ($83.8M)
- Enterprise value
- $110.7M